GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-complexed tripeptide first isolated from human plasma albumin and is supplied exclusively for laboratory and preclinical research applications
Stress may result from negative or positive events, including both eustress and distress (roughly meaning challenge and overload, respectively)
Centers for Disease Control and Prevention (CDC) Surveillance for Lyme diseaseUnited States, 1992-2006
For Canadians looking to address post-weight-loss skin laxity across large body areas like the abdomen, arms, and thighs, injectable GHK-Cu offers a level of systemic reach that topical products simply cannot match
In May 2012, researchers started a Phase I dose-finding trial of adipotide in patients with metastatic prostate cancer and obesity, all for whom standard treatment options were not an option